224 related articles for article (PubMed ID: 25873248)
1. Fibromyalgia, milnacipran and experimental pain modulation: study protocol for a double blind randomized controlled trial.
Macian N; Pereira B; Shinjo C; Dubray C; Pickering G
Trials; 2015 Apr; 16():134. PubMed ID: 25873248
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of milnacipran 100 mg/day in patients with fibromyalgia: results of a randomized, double-blind, placebo-controlled trial.
Arnold LM; Gendreau RM; Palmer RH; Gendreau JF; Wang Y
Arthritis Rheum; 2010 Sep; 62(9):2745-56. PubMed ID: 20496365
[TBL] [Abstract][Full Text] [Related]
3. Effect of Milnacipran Treatment on Ventricular Lactate in Fibromyalgia: A Randomized, Double-Blind, Placebo-Controlled Trial.
Natelson BH; Vu D; Mao X; Weiduschat N; Togo F; Lange G; Blate M; Kang G; Coplan JD; Shungu DC
J Pain; 2015 Nov; 16(11):1211-9. PubMed ID: 26335989
[TBL] [Abstract][Full Text] [Related]
4. Milnacipran for the treatment of fibromyalgia in adults: a 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial.
Clauw DJ; Mease P; Palmer RH; Gendreau RM; Wang Y
Clin Ther; 2008 Nov; 30(11):1988-2004. PubMed ID: 19108787
[TBL] [Abstract][Full Text] [Related]
5. Segregating the cerebral mechanisms of antidepressants and placebo in fibromyalgia.
Jensen KB; Petzke F; Carville S; Choy E; Fransson P; Gracely RH; Vitton O; Marcus H; Williams SC; Ingvar M; Kosek E
J Pain; 2014 Dec; 15(12):1328-37. PubMed ID: 25283470
[TBL] [Abstract][Full Text] [Related]
6. Milnacipran poorly modulates pain in patients suffering from fibromyalgia: a randomized double-blind controlled study.
Pickering G; Macian N; Delage N; Picard P; Cardot JM; Sickout-Arondo S; Giron F; Dualé C; Pereira B; Marcaillou F
Drug Des Devel Ther; 2018; 12():2485-2496. PubMed ID: 30127596
[TBL] [Abstract][Full Text] [Related]
7. A European multicenter randomized double-blind placebo-controlled monotherapy clinical trial of milnacipran in treatment of fibromyalgia.
Branco JC; Zachrisson O; Perrot S; Mainguy Y;
J Rheumatol; 2010 Apr; 37(4):851-9. PubMed ID: 20156949
[TBL] [Abstract][Full Text] [Related]
8. Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia.
Welsch P; Üçeyler N; Klose P; Walitt B; Häuser W
Cochrane Database Syst Rev; 2018 Feb; 2(2):CD010292. PubMed ID: 29489029
[TBL] [Abstract][Full Text] [Related]
9. Resting state connectivity correlates with drug and placebo response in fibromyalgia patients.
Schmidt-Wilcke T; Ichesco E; Hampson JP; Kairys A; Peltier S; Harte S; Clauw DJ; Harris RE
Neuroimage Clin; 2014; 6():252-61. PubMed ID: 25379438
[TBL] [Abstract][Full Text] [Related]
10. Effects of milnacipran on clinical pain and hyperalgesia of patients with fibromyalgia: results of a 6-week randomized controlled trial.
Staud R; Lucas YE; Price DD; Robinson ME
J Pain; 2015 Aug; 16(8):750-9. PubMed ID: 25998206
[TBL] [Abstract][Full Text] [Related]
11. Dual reuptake inhibitor milnacipran and spinal pain pathways in fibromyalgia patients: a randomized, double-blind, placebo-controlled trial.
Matthey A; Cedraschi C; Piguet V; Besson M; Chabert J; Daali Y; Courvoisier D; Montagne A; Dayer P; Desmeules JA
Pain Physician; 2013; 16(5):E553-62. PubMed ID: 24077206
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of milnacipran in patients with fibromyalgia.
Gendreau RM; Thorn MD; Gendreau JF; Kranzler JD; Ribeiro S; Gracely RH; Williams DA; Mease PJ; McLean SA; Clauw DJ
J Rheumatol; 2005 Oct; 32(10):1975-85. PubMed ID: 16206355
[TBL] [Abstract][Full Text] [Related]
13. Combining cognitive-behavioral therapy and milnacipran for fibromyalgia: a feasibility randomized-controlled trial.
Ang DC; Jensen MP; Steiner JL; Hilligoss J; Gracely RH; Saha C
Clin J Pain; 2013 Sep; 29(9):747-54. PubMed ID: 23446065
[TBL] [Abstract][Full Text] [Related]
14. The Effects of Milnacipran on Sleep Disturbance in Fibromyalgia: A Randomized, Double-Blind, Placebo-Controlled, Two-Way Crossover Study.
Ahmed M; Aamir R; Jishi Z; Scharf MB
J Clin Sleep Med; 2016 Jan; 12(1):79-86. PubMed ID: 26414990
[TBL] [Abstract][Full Text] [Related]
15. Clinical potential of milnacipran, a serotonin and norepinephrine reuptake inhibitor, in pain.
Leo RJ; Brooks VL
Curr Opin Investig Drugs; 2006 Jul; 7(7):637-42. PubMed ID: 16869117
[TBL] [Abstract][Full Text] [Related]
16. Milnacipran for neuropathic pain and fibromyalgia in adults.
Derry S; Gill D; Phillips T; Moore RA
Cochrane Database Syst Rev; 2012 Mar; 3(3):CD008244. PubMed ID: 22419330
[TBL] [Abstract][Full Text] [Related]
17. The efficacy and safety of milnacipran for treatment of fibromyalgia. a randomized, double-blind, placebo-controlled trial.
Mease PJ; Clauw DJ; Gendreau RM; Rao SG; Kranzler J; Chen W; Palmer RH
J Rheumatol; 2009 Feb; 36(2):398-409. PubMed ID: 19132781
[TBL] [Abstract][Full Text] [Related]
18. A double-blind placebo-controlled trial of milnacipran in the treatment of fibromyalgia.
Vitton O; Gendreau M; Gendreau J; Kranzler J; Rao SG
Hum Psychopharmacol; 2004 Oct; 19 Suppl 1():S27-35. PubMed ID: 15378666
[TBL] [Abstract][Full Text] [Related]
19. Longterm therapeutic response to milnacipran treatment for fibromyalgia. A European 1-year extension study following a 3-month study.
Branco JC; Cherin P; Montagne A; Bouroubi A;
J Rheumatol; 2011 Jul; 38(7):1403-12. PubMed ID: 21459941
[TBL] [Abstract][Full Text] [Related]
20. Functional magnetic resonance imagery (fMRI) in fibromyalgia and the response to milnacipran.
Mainguy Y
Hum Psychopharmacol; 2009 Jun; 24 Suppl 1():S19-23. PubMed ID: 19479905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
